ABUS

#2156
Arbutus Biopharma Corporation Common Stock
4.66
-0.64%
版块:
基础:
利润货币:
日范围
4.66
4.66
年范围
2.71
5.10
日变化
-0.64%
每月变动
+11.75%
6个月变化
+27.32%
年变化
+38.69%
前一天收盘价
4.69
Open
4.66
Bid
Ask
Low
4.66
High
4.66
交易量
230
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

新闻